Insulin List Prices Would Be Lowered To 2006 Levels Under House Bill

Rebates would be prohibited and insurance coverage required without restrictions for insulin products with steep price roll-backs under bill from Reps. Diana DeGette, D-CO, and Tom Reed, R-NY.

Insulin pen
Bill Would Prohibit Rebates In Return For Lower Prices

Bipartisan legislation co-sponsored by Reps. Diana DeGette, D-CO, and Tom Reed, R-NY, seeks to drive down insulin costs by eliminating rebates for products whose list prices have been returned to 2006 levels.

The Insulin Price Reduction Act would offer manufacturers incentives for dramatically lowering insulin prices by prohibiting rebates for insulins...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access